Home › Funds › PFM Health Sciences, LP › DHR

PFM Health Sciences, LP position in DHR

DANAHER CORP DEL · Industrials

PFM Health Sciences, LP reported holding 45,663 shares of DHR (DANAHER CORP DEL) in its Q3 2026 13F filing — a position valued at US$10.1M, representing 1.03% of its reported portfolio and ranking #39 among its reported holdings. PFM Health Sciences, LP has disclosed DHR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)45.66K sh
Reported value held$10.12M
Portfolio Weight1.03%
First reportedQ3 2023
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's DHR position evolved

PFM Health Sciences, LP first disclosed a stake in DHR in Q3 2023 at 175,690 shares (US$43.6M). Across 9 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 45,663 shares valued at US$10.1M. Notable position changes include a 29% trim in Q4 2023 (shares rose 8% over the following quarter), a 44% increase in Q2 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 175.69K $43.59M New
Q4 2023 125.52K $29.04M Reduce
Q1 2024 125.52K $31.34M Hold
Q2 2024 125.52K $31.36M Hold
Q3 2024 125.52K $34.90M Hold
Q4 2024 125.52K $28.81M Hold
Q1 2025 112.47K $23.06M Reduce
Q2 2025 161.41K $31.89M Add
Q3 2026 45.66K $10.12M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DHR and 13F data

DHR (DANAHER CORP DEL) is a Industrials company. 23 other funds we track also report a position in DHR — the largest reported positions include Fidelity Management & Research (FMR) (US$8.58B), Capital International Investors (US$4.02B), Capital Research Global Investors (US$3.54B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DHR

All DHR fund holders →

FAQ

How long has PFM Health Sciences, LP held DHR?

PFM Health Sciences, LP has disclosed DHR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in DHR?

As of Q3 2026, PFM Health Sciences, LP holds 45.66K shares of DHR (DANAHER CORP DEL), valued at $10.12M, representing 1.03% of its reported portfolio and ranking #39.

Has PFM Health Sciences, LP been buying or selling DHR?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in DHR.

Which other funds hold DHR?

Other major institutional holders of DHR include Fidelity Management & Research (FMR), Capital International Investors, Capital Research Global Investors, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.